Dana–Farber Cancer Institute-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2023

  1. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

    Blood Advances